TTD | Drug: D0F1UZ

Drug General Information
Drug ID	D0F1UZ
Former ID	DCL000696
Drug Name	Amitriptyline+ketamine
Drug Type	Small molecular drug
Indication	Neuropathic pain [ICD9: 356.0, 356.8; ICD10:G64, G90.0]		Phase 3	[544412]
Therapeutic Class	Analgesics
Company	EpiCept Pharmaceuticals
Formula	C20H17ClN4O2S
PubChem Compound ID	24784105
Target and Pathway
Target(s)	NMDA receptor	Target Info	Antagonist	[536374]
References
Ref 544412	A Phase III Randomized, Placebo-Controlled Study of Topical Amitriptyline and Ketamine for Chemotherapy-Induced Peripheral Neuropathy (CIPN): A University of Rochester CCOP Study of 462 Cancer Survivors. Support Care Cancer. 2014 July; 22(7): 1807-1814.
Ref 536374	Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information